View More Recent Stories

Nov 25, 2024 07:43AM Biohaven Pharma (BHVN) Falls 13% Following Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity
Nov 25, 2024 07:32AM Biohaven Pharma (BHVN) Provides Update on Taldefgrobep Alfa Development Program
Nov 13, 2024 11:18AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $75 at TD Cowen
Nov 13, 2024 06:44AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $66 at RBC Capital
Nov 12, 2024 04:09PM Biohaven Pharma (BHVN) Misses Q3 EPS by 4c
Oct 15, 2024 06:12AM BofA Securities Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 7, 2024 04:08PM Leerink Partners Reiterates Outperform Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 7, 2024 03:41PM BTIG Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 7, 2024 10:20AM Baird Reiterates Outperform Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 7, 2024 06:16AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $63 at BofA Securities
Oct 3, 2024 06:01AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $68 at JPMorgan
Oct 1, 2024 07:43AM TD Cowen Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 1, 2024 06:14AM Biohaven Pharma (BHVN) Prices 5.26M Share Offering at $47.50/sh
Sep 30, 2024 05:01PM After-hours movers: IGM Biosciences, Biohaven Pharma, Acadia Realty Trust
Sep 30, 2024 04:06PM Biohaven Pharma (BHVN) Announces Proposed $250M Share Offering
Sep 30, 2024 07:31AM Biohaven Pharma (BHVN) Initiates Pivotal Trial of BHV-2100 for Treatment of Migraine
Sep 24, 2024 09:45AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $60 at Leerink Partners
Sep 24, 2024 06:47AM H.C. Wainwright Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Sep 24, 2024 06:21AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $62 at BofA Securities
Sep 24, 2024 06:14AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $68 at RBC Capital
Sep 23, 2024 01:59PM TD Cowen Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Sep 23, 2024 12:17PM BTIG Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN), PT $59
Sep 23, 2024 12:17PM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $60 at Baird
Sep 23, 2024 11:01AM Piper Sandler Reiterates Overweight Rating on Biohaven Pharmaceutical Holding (BHVN)
Sep 23, 2024 08:19AM Biohaven Pharma (BHVN) Climbs 15% Following Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia
Sep 23, 2024 07:30AM Biohaven Pharma (BHVN) Reports Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia
Sep 16, 2024 06:26AM Jefferies Starts Biohaven Pharmaceutical Holding (BHVN) at Buy
Sep 4, 2024 05:52AM Bernstein SocGen Group Starts Biohaven Pharmaceutical Holding (BHVN) at Outperform
Aug 9, 2024 06:40AM Biohaven Pharma (BHVN) Misses Q2 EPS by 172c
Jul 30, 2024 07:17AM RBC's biotech survey shows investors more bearish vs. last time
Jul 24, 2024 02:43AM Morgan Stanley Starts Biohaven Pharmaceutical Holding (BHVN) at Overweight
Jul 9, 2024 07:00PM 2Q24 U.S. biotech earnings preview
Jul 1, 2024 07:01AM Benitec Biopharma (BNTC) Announces Appointment of Kishen Mehta to its Board of Directors
Jun 25, 2024 10:32AM TD Cowen Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Jun 17, 2024 06:20AM RBC Capital Reiterates Outperform Rating on Biohaven Pharmaceutical Holding (BHVN)
View More Recent Stories